Needham analyst Joseph Stringer has maintained their neutral stance on VRTX stock, giving a Hold rating today. Joseph Stringer has given his Hold rating due to a combination of factors surrounding ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...

Vertex won FDA approval for its newest CF drug, Alyftrek on Dec. 20, 2024. This therapy seems likely to become the new standard of care ... 1/2 study evaluating VX-522, a messenger RNA therapy ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex also is busy working on a potential cure for type 1 diabetes. It's testing zimislecel in a phase 3 study for treating T1D patients with severe hypoglycemic events. A second T1D program, VX ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

If you're in the market for a new scope, I recommend VX-6HD GEN 2 models over standard VX-6HD models. Hunters shouldn't swap every VX-HD scope they already have on their rifles for a GEN 2 unless ...

He signed a $260 million deal, but there are just three years left. He's owed $74 million, but some is covered by the Colorado Rockies and if a trade gets done it's like the St. Louis Cardinals ...

Magic Johnson is over the moon about the Lakers' surprise acquisition of former Dallas Mavericks superstar Luka Doncic over the weekend. On Sunday, the Showtime-era legend posted no fewer than ...